D e r L e m e r e V i e w hacettepe T›p Dergisi

25

D hormonu: Güncel geliflmeler

C i l t   4 2   •   S a y ›   1   •   2 0 1 1

4.

Nemere I, Carson F. Membrane receptors for steroid hormo-

nes: a case for spesific cell surface binding sites for vitamin

D metabolites and estrogens. Biochem Biophys Res Com

1998; 248:442-9.

5.

Norman AW. Receptors for 1,25(OH)

2

D

3

: past, present and

future. J Bone Miner Res 1998; 13:1360-9.

6.

De Luca HF, Cantorna MT. Vitamin D: its role and uses in

immunology. FASEB J 2001; 15:2579-85.

7.

Bouillon R, Cameliet G, Daci E, Seagart S ,Verstuyf A. Vita-

min D Metabolism and Action. Osteoporos Int 1998; 8:13-9. 

8.

Barger-Lux MJ, Heaney RP, Lanspa SJ, Healy JC, DeLuca HF.

An investigation of sources of variation in calcium absorti-

on efficiency. J Clin Endocrinol Metab 1995; 80:406-11. 

9.

Selles J, Bellido T, Boland R. Modulation of calcium uptake

in cultured cardiac muscle cells by 1,25 dihydroxyvitamin

D3. J Mol Cell Cardiology 1994; 26:1593-9.

10. Poiton JJ, Francis MJ, Smith R. Effect of vitamin D defici-

ency on sarcoplasmic reticulum function and troponin C

concentration of rabit skeletal muscle. Clin Science 1979;

57:257-63.

11. Birge SJ, Haddad JG. 25 hydroxycholecalciferol stimulation

of muscle metabolism. J Clin Invest 1975; 56:1100-7.

12. Liu PT, Stenger S, LI H, Wenzel L, Tan BH, Krutzik SR, et al. Ac-

tivation of human TLR 2/1 triggers a vitamin D receptor-de-

pendent antimicrobial response. Science 2006; 311:1770-3. 

13. Quarles LD. Endocrine functions of bone in mineral meta-

bolism regulation. J Clin Invest 2008; 118:3820-8.

14. Steingrimsdottr L, Gunnarsson O, Indridason OS, Franzon

L, Sigurdsson G. Relationship between serum parathyroid

hormone levels, vitamin D sufficiency, and calcium intake

JAMA 2005; 294:2336-41.

15. Zitterman A. Review article: vitamin D in preventive medi-

cine: are we ignoring the evidence? Brit J Nutr 2003;

89:552-72.

16. Giovannucci E. Expanding roles of vitamin D. J Clin En-

docrinol Metab 2009; 94:418-20.

17. Gallagher JC, Sai AJ. Vitamin D insufficiency, deficiency,

and bone health. J Clin Endocrinol Metab 2010; 95:2630-3.

18. Kuchuc NO, Van Schoor NM, Pluijm SM, Chines A, Lips P.

Vitamin D status, parathyroid function bone turnover, and

BMD in postmenopausal women with osteoporosis: global

perspective. J Bone Miner Res 2009; 24:693-701.

19. Dawson-Hughes B, Heaney RP, Holick MF, Ips P, Meunier

PJ, Vieth R. Estimates of optimal vitamin D status. Osteopo-

ros Int 2005; 16:713-6.

20. Melhius H, Snellman G, Gedeborg R, Byberg L, Berglund L,

Mallmin H, et al. Plasma 25 Oh hydroxyvitmin D levels and

fracture risk in a community-based cohort of elderly men in

Sweden. J Clin Endocrinol Metab 2010; 95:2637-45.

21. Nesby-O’Dell S, Scanlon KS, Cogswell ME, Gillipspie C,

Holli BW, Looker AC, et al. Hypovitaminosis D prevalence

and deterninants among African American and white wo-

men of reproductive age. Third National Health and Nutri-

tion Examination. Am J Clin Nutr 2002; 76:187-92.

22. O’Riordan JL. Rickets, from history to molecular bilogy, from

monkeys to YACS. J Endocrinol 1997; 154(Suppl):S3-S13.

23. Reginato AJ, Falasca GF, Pappu R, Mc Knight B, Agha A.

Muscloskeletal manifestations of osteomalacia. Report of

26 cases and literature review. Sem Arthritis Rheum 1999;

28:287-304.

24. Menkes CJ. Clinical manifestations and etiology of oste-

omalacia. Up to date 1999: 7.

25. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25

OHD

3

receptors and activities in muscle. J Bone Miner Res

2004; 19:370-8.

26. Bischoff- Ferrari HA, Dietrich T, Orav EJ, Hu FB, Zhang Y,

Karlson EW, et al. Higher 25 hydroxyvitamin D concentra-

tions are associated with better lower extremity function in

both active and inactive persons aged > or = 60 y. Am J Clin

Nutr 2004; 80:752-8.

27. Broe KE, Chen TC, Weinberg J, Bischoff-Ferrari HA, Holick

MF, Kiel DP. A higher dose of vitamin D reduces the risk of

falls in nursing home residents: a randomizd multiple-dose

study. J Am Geriatr Soc 2007; 55:234-9.

28. Adams JS, Hevison M. Unexpected actions of vitamin D:

new perspectives on the regulation of innate and adaptive

immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.

29. Nnoaham KE, Clarke A. Low serum vitamin D levels and

tuberculosis:a systemic review and meta-analysis. Int J Epi-

demiol 2008; 37:113-9.

30. Ginde AA, Mansbach JM, Camargo Jr Ca. Association betwe-

en serum 25 hydroxyvitamin D level and upper respiratory

tract infection in the Third National Health and Nutrition

examination Survey. Arch Intern Med 2009; 169:384-90.

31. Munger KLM, Zhang S M, O’Reilly E. Vitamin D intake and

incidence of multiple sclerosis. Neurology 2004; 62:60-5.

32. Merlino LA, Curtis J, Mikuls TR, Crhan JR, Criswell LA, Sa-

ag KG. Vitamin D intake is inversely associated with rhe-

matoid arthritis: results from the Iowa Women’s Health

Study. Arthritis Rheum 2004; 50:72-7.

33. Cutolo M, Otsa K. Vitamin D, immunity and lupus. Lupus

2008; 17:6-10.

34. Kumar R. Prenatal factors and the development of asthma.

Curr Opinion Pediatrics 2008; 20:682-7. 

35. Hansdottir S, Monich MM, Hinde SL, Lovan N, Look DC,

Hunnighake GW. Respiratory epithelial cells convert inac-

tive vitamin D to its active form: potential effects on host

defense. J Immunology 2008; 181:7090-9.

36. Lee S, Clark SA, Gill RK, Christakos S. 1,25 dihydroxyvita-

min D

3

and pancreatic 

β 

cell function: vitamin D receptors,

gene expression, and insulin secretion. Endocrinology

1994; 134:1602-10.

37. Hyppönen E, Laara, E, Reunanen A, Jarvelin MR, Virtanen

SM. Intake of vitamin D and risk of Type 1 diabetes: a birth

cohort study. Lancet 2001; 58:1500-3.

38. Zipitis CS, Akobeng AK. Vitamin D supplementation in

early childhood and risk of type 1 diabetes: a systematic re-

view and meta-analysis. Arch Dis Child 2008; 93:512-7.

39. EURODIAB Substudy 2 Study Group. Vitamin D supple-

ment in early childhood and the risk for type 1 (insulin de-

pendent) diabetes mellitus. Diabetologia 1999; 42:51-4.

40. Penckofer S, Kouba J, Wallis DE, Emanuela MA. Vitamin D

and diabetes: let the sunshine in. Diabetes Educ 2008;

34:939-40, 942, 944.

41. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes

mellitus: state of art. Trends Endocrinol Metab 2005;

16:261-6.

26

Sözen

H

A C E T T E P E  

T

I P  

D

E R G ‹ S ‹

27

D hormonu: Güncel geliflmeler

C i l t   4 2   •   S a y ›   1   •   2 0 1 1

42. Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is

associated with insulin resistance and the 

β 

cell dysfuncti-

on. Am J Clin Nutr 2004; 79:820-5.

43. Pittas AG, Dawson-Hughes B, Li T. Vitamin D and calcium

intake in relation to type 2 diabets in women. Diabetes Ca-

re 2006; 29:650-6.

44. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vi-

tamin D and calcium in type 2 diabetes: a systemic review

and meta-analysis. J Clin Endocrinol Metab 2007; 92:2017-

29.

45. Wortsman J, Matsuakka LY, Chen TC, Lu Z, Holick MF. Dec-

reased bioavailability of vitamin D in obesity. Am J Nutr

2000; 72:690-3.

46. Parikh SJ, Edlman M, Uwaifo GI, Freedman R, Semega-Jan-

neh Mreynolds J. The relationship between obesity and se-

rum 1,25 dihydroxy vitamin D concentrations in healty

adults. J Clin Endocrinol Metab 2004; 89:1196-9. 

47. Kremer R, Campbell PP, Reinhart T, Gilsanz V. Vitamin D

status and its relationship to boy fat, final height and peak

bone mass in young women. J Clin Endocrinol Metab

2009; 94:67-73. 

48. Yetley EA. Assessing the vitamin D status of the US popula-

tion. Am J Clin Nutr 2008; 88:558-64.

49. De Luis DA, Pacheco D, Izaola O, Terroba MC, Cuellar L,

Matin T. Clinical results and nutritional consequences of

biliopancreatic diversion: three years of follow-up. Ann

Nutr Metab 2008; 53:234-9.

50. Adams JA, Hewison M. Update in vitamin D.  J Clin Endoc-

rinol Metab 2010; 95:471-8. 

51. Martins D, Wolf M, Pan D. Prevelance of cardiovascular fac-

tors ad the serum levels of 25 hydroxyvitamin D in the

United States: data from the third National Health and

Nutrition Examination Surveys. Arch Intern Med 2007;

167:1159-65.

52. Wang J, Pencina MJ, Booth SL, Jacques PF, Ingelson E, Lani-

er K, et al. Vitamin D deficiency, and risk of cardioascular

disease Circulation 2008;117 (online publication Jan 7).

53. Sarnak MJ, Levey AS, Schoolwerth AC. Kidney disease as a

risk factor for development of cardiovascular disease: a sta-

tement from the American Heart Association Councils on

Kidney in Cardiovascular disease, High Blood Pressure Re-

search, Clinical Cardiology, and Epidemiology, and Preven-

tion. Circulation 2003; 108:2154-69.

54. Liu YC. Vitamin D regulation of the renin-angiotensin.

System J Cell Biochem 2003; 88:327-31.

55. Schwartz GG. Vitamin D and the epidemiology of prostate

cancer. Seminars in Dialysis 2005; 18:276-89.

56. Fescanich D, Ma J, Fuchs CS, Kirkner GJ, Hankinson SE,

Holli BW, et al. Plasma vitamin D metabolites an the risk of

colorectal cancer in women. Cancer Epidemiol Biomarkers

Prev 2004; 13:1502-8.

57. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Gi-

ovannucci EL. A nested case control study of plasma 25

hydroxyvitamin D concentrations an risk of colorectal can-

cer. J Natl Cancer Ins 2007; 99:1120-9.

58. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, He-

aney PH. Vitamin and calcium supplementation reduces

cancer risk: results of a randomized trial. Am J Clin Nutr

2007; 85:1586-91.

59. Grant WB. An estimate of premature cancer mortality in

the US due to inadequate doses of solar ultraviolet-B radi-

ation. Cancer 2002; 94;1867-75.

60. Richards JB, Valdes AM, Gardner JP, Paximadas D, Kimu M,

Nessa A, et al. Higher serum vitamin D concentrations are

associated with longer leucocyte telemere lenght in women

Am J Clin Nutr 2007; 86:1420-5.

61. El Sonbathy MR, Abdul-Gaffar NU. Vitamin D deficiency in

veiled Kuwaiti women. Eur J Clin Nutr 1996; 315-8.

62. Fonsec V, El Hazmi M, Tongia R, Abu-Aisha HH. Exposure

to sunlight and vitamin D deficiency in Saudi Arabian wo-

men. Postgrad Med J 1984 ;60:589-91.

63. Gullu S, Erdogan MF, Uysal AR, Baskal N, Kamel AN, Erdo-

gan G. A potential risk for osteomalacia due to sociocultu-

ral lifestyle in Turkish women. Endoc J 1998; 45:675-8.

64. Alagol F, Shihadeh Y, Boztepe H, Tanakol R, Yarman S, Aziz-

lerli H, Sandalci O. Sunlight exposure and vitamin D defici-

ency in Turkish women. J Endocrin Invest 2000; 23;173-7. 

65. Hollick MF. Sunlight and vitamin D for bone health and

prevention of autoimmune diseases, cancers, and cardi-

ovascular diseases. Am J Clin Nutr 2004; 80:1678-88.

66. Barzel US. Vitamin D deficiency. A risk factor fo osteomala-

cia in the aged. J Am Geriatr Soc 1993; 31:598-601. 

67. Finch PJ, Ang L, Colstan KW, Nispet J, Maxwell JD. Blunted

seasonal variation in serum 25 hydroxy vitamin D and inc-

reased risk of osteomalacia in vegeterian London Asians.

Eur J Clin Nutr 1992; 46:509-15. 

68. Cornish DA, Maluleke V, Mhlanga T. An investigation into

a possible relationship vitamin D hormone calcium and

magnesium in a normal pigmented and rural black popula-

tion in the Northern province of South Africa. Biofactors

2000; 11:35-8.

69. Glerup H , Mikkelson K, Poulsen L, Hass E, Overbeck S,

Thomsen J, et al. Commonly recommended daily intake of

vitamin D is not sufficient if sunlight exposure is limited. J

Intern Med 2000; 247:260-8.

70. Bischoff-Ferrari HA, Giovannuci E, Wlliett WC, et al. Esti-

mation of optimal serum concentration s of 25hydroxyvi-

tamin D for multiple health outcomes. Am J Clin Nutr

2006; 84:18-28.

71. Vitamin deficiency: implications across the life span. J Nur-

se Practitioners 2008; 4:448-56.

72. Rosen CJ. Vitamin D deficiency. N Engl J Med 2011;

364:248-54.